Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director comp.
|
|
Oncology Institute, Inc. (DFPH)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/10/2023 |
8-K
| Investor presentation |
| 08/08/2023 |
8-K
| Quarterly results |
| 06/12/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/10/2023 |
8-K
| Quarterly results |
| 03/27/2023 |
8-K
| Quarterly results |
| 03/09/2023 |
8-K
| Quarterly results |
| 12/01/2022 |
8-K
| Quarterly results |
| 11/14/2022 |
8-K
| Investor presentation |
| 11/09/2022 |
8-K
| Quarterly results |
| 09/22/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/15/2022 |
8-K
| Investor presentation |
| 08/09/2022 |
8-K
| Quarterly results |
| 08/09/2022 |
8-K
| Quarterly results |
| 07/15/2022 |
8-K
| Quarterly results |
| 05/11/2022 |
8-K
| Other Events Interactive Data |
| 05/10/2022 |
8-K
| Quarterly results |
| 03/11/2022 |
8-K
| Quarterly results |
| 03/10/2022 |
8-K
| Quarterly results |
| 03/07/2022 |
8-K
| Quarterly results |
| 12/09/2021 |
8-K
| Quarterly results |
| 11/18/2021 |
8-K
| Director compensation was amended/approved|
Docs:
|
"THIRD AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF DFP HEALTHCARE ACQUISITIONS CORP. ***** DFP Healthcare Acquisitions Corp., a corporation organized and existing under the laws of the state of Delaware , does hereby certify as follows: 1. The original certificate of incorporation of the Corporation was filed with the Secretary of State of Delaware on November 1, 2019 . The name under which the Original Certificate of Incorporation was filed is “DFP Healthcare Acquisitions Corp.” 2. The Corporation’ s First Amended and Restated Certificate of Incorporation, which amended and restated the provisions of the Original Certificate of Incorporation, was duly adopted in accordance with Sections 228, 242 and 245 of the General Corporation Law of the State of Delaware, as amended from time ...",
"Amended & Restated Bylaws of The Oncology Institute, Inc.",
"ARTICLE I. PURPOSE The Plan’ s purpose is to enhance the Company’ s and its Related Entities’ ability to attract, retain and motivate persons who make important contributions to the Company or its Related Entities by providing these individuals with equity ownership opportunities and/or equity-linked compensatory opportunities. Capitalized terms used in the Plan are defined in Article XI. ARTICLE II. ELIGIBILITY Service Providers are eligible to be granted Awards under the Plan as determined by the Administrator from time to time, subject to the limitations described herein. ARTICLE III. ADMINISTRATION AND DELEGATION 3.1    Administration . The Plan is administered by the Administrator. The Administrator has authority to determine which Service Providers receive Awards, g...",
"ARTICLE I. PURPOSE The purpose of this Plan is to assist Eligible Employees of the Company and its Designated Subsidiaries in acquiring a stock ownership interest in the Company. The Plan consists of two components: the Section 423 Component and the Non-Section 423 Component. The Section 423 Component is intended to qualify as an “employee stock purchase plan” under Section 423 of the Code and shall be administered, interpreted and construed in a manner consistent with the requirements of Section 423 of the Code. The Non-Section 423 Component authorizes the grant of rights which need not qualify as rights granted pursuant to an “employee stock purchase plan” under Section 423 of the Code. Rights granted under the Non-Section 423 Component shall be granted pursuant to separate Offerings con...",
"TOI Parent, Inc.",
"UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION The following unaudited pro forma condensed combined balance sheet as of September 30, 2021 and the unaudited pro forma condensed combined statements of operations for the year ended December 31, 2020 and nine months ended September 30, 2021 present the combined financial information of DFP and TOI after giving effect to the Business Combination and related adjustments described in the accompanying notes. DFP and TOI are collectively referred to herein as the “Companies,” and the Companies, subsequent to the Business Combination, are referred to herein as the “Combined Company” or “New TOI.” The unaudited pro forma condensed combined financial information has been prepared in accordance with Article 11 of Regulation S-X, as amend..." |
|
| 10/22/2021 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 10/12/2021 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 06/28/2021 |
8-K
| Director compensation was amended/approved|
Docs:
|
"Agreement and Plan of Merger, by and among DFP Healthcare Acquisitions Corp. Orion Merger Sub I, Inc., Orion Merger Sub II, LLC and TOI Parent Inc",
"Form of Subscription Agreement",
"Form of Deerfield Subscription Agreement",
"Stockholder Support Agreement, by and among DFP Healthcare Acquisitions Corp., TOI Parent Inc., DFP Sponsor LLC and the other signatories thereto",
"Company Support Agreement, by and among DFP Healthcare Acquisitions Corp., TOI Parent Inc. and the other signatories thereto",
"Consent and Waiver Letter, by and among DFP Healthcare Acquisitions Corp., DFP Sponsor LLC, Deerfield Private Design Fund IV, L.P. and Deerfield Partners, L.P" |
|
| 06/28/2021 |
8-K
| Quarterly results |
| 05/18/2021 |
8-K
| Quarterly results |
| 04/28/2020 |
8-K
| Other Events, Financial Statements and Exhibits |
| 03/19/2020 |
8-K
| Quarterly results |
| 03/13/2020 |
8-K
| Quarterly results |
|
|